APROKAM

This brand name is authorized in Austria, Finland, France, Hong Kong SAR China, Netherlands, Poland, Romania, Tunisia, Turkey, UK.

Active ingredients

The drug APROKAM contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII R8A7M9MY61 - CEFUROXIME SODIUM
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
APROKAM Powder for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AA27		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA27

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	416325
FR	Base de données publique des médicaments	60378168
GB	Medicines & Healthcare Products Regulatory Agency	217976
HK	Department of Health Drug Office	66973
NL	Z-Index G-Standaard, PRK	103608
PL	Rejestru Produktów Leczniczych	100288430, 100404898
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59119001, W59119002, W59119003, W59119004
TN	Direction de la Pharmacie et du Médicament	8443141, 8443142H
TR	İlaç ve Tıbbi Cihaz Kurumu	8680177220108, 8680177220115, 8680177220122